Skip to content

Multi-center Observation of the Natural Course of Inherited Retinal Dystrophies

Multi-center Observation of the Natural Course of Inherited Retinal Dystrophies

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03691168
Acronym
RID
Enrollment
500
Registered
2018-10-01
Start date
2018-06-01
Completion date
2023-05-30
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inherited Retinal Dystrophies

Keywords

Inherited retinal dystrophies, Gene screen

Brief summary

Based on a clinical multi-center study of the natural course of inherited retinal dystrophies in Chinese population, screening fundus imaging indicators for patients with Chinese inherited retinal dystrophies, describing the clinical features of Chinese patients with inherited retinal dystrophies, and establishing a diagnosis of hereditary retinal diseases - Follow-up norms; establish a network-based multi-center diagnosis and follow-up platform; obtain a biological sample library of hereditary retinal diseases mainly in China. The research will further improve and enrich the genotype, phenotypic characteristics and natural course of Chinese inherited retinal dystrophies, in order to promote the clinical evaluation of clinical inherited retinal dystrophies and the standardization of genetic diagnosis. It is also the evidence for the best timing for future gene therapy, to obtain the best therapeutic effect, and to provide a theoretical basis for achieving precise treatment.

Interventions

None listed

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with IRDs whose mutations have been identified 2. 4\ 70 years old 3. Complete 4 basic examinations of the eye: Corrective vision; fundus photography; OCT; ERG

Exclusion criteria

1. Has participated in other interventional treatment studies; 2. Patients with severe systemic diseases, mental dysplasia, mental illness; 3. Unable to accept eye examination patients; 4. Traumatic retinopathy, retinal inflammatory disease, paraneoplastic retinopathy, drug toxicity, and rare diseases such as diffuse unilateral subacute optic retinitis 5. At the initial visit, the patient's binocular vision is displayed as no light. 6. Both eyes have a history of internal eye surgery

Design outcomes

Primary

MeasureTime frameDescription
Visual acuity60 monthsA typical Snellen chart that if frequently used for visual acuity testing

Countries

China

Contacts

Primary Contacthuixun Jia, Master
jiahuixun@163.com+86 18017317575
Backup ContactWenqiu Wang, PHD
wangwenqiu@126.com+86 13817062881

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026